Cite

HARVARD Citation

    Sandborn, W. et al. (n.d.). OC-043 Long term efficacy and safety of ustekinumab for crohn's disease: results from im-uniti long-term extension through 2 years. Gut. p. A22. [Online]. 
  
Back to record